Prescribing Information Important Safety Information
About CSID

What is Congenital Sucrase-Isomaltase Deficiency?

What is Congenital Sucrase-Isomaltase Deficiency?

Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare disorder that affects your ability to digest certain sugars due to absent or low levels of two digestive enzymes, sucrase and isomaltase. Sucrase and isomaltase are involved in the digestion of sugar and starches. Sucrase is the intestinal enzyme that aids in the breakdown of sucrose (table sugar) into glucose and fructose, which are used by the body as fuel. Isomaltase is one of several enzymes that help digest starches.1, 2

CSID is also known as genetic sucrase deficiency and congenital sucrose intolerance. This disorder occurs with equal frequency in males and females.2

Sugar

Sucrose, a sugar found in fruits and known as table sugar, and maltose, a sugar found in grains, are called disaccharides because they are made of two simple sugars. Disaccharides are broken down into simple sugars during digestion by intestinal enzymes. Sucrose is broken down into glucose and fructose, and maltose is broken down into two glucose molecules. Individuals with CSID have an impaired ability to break down these disaccharides (sucrose and maltose) into simple sugars called monosaccharides (glucose and fructose) that the body uses as fuel. Typically, an individual with CSID has decreased, often absent, sucrase activity, decreased-to-normal isomaltase activity, and reduced-maltase activity.3

Although simple sugars are the main carbohydrate absorbed in the digestive tract, monosaccharides (glucose, fructose, and galactose) are rarely found in human diets. Instead, disaccharides (for example, sucrose, lactose, and maltose) are more common in the human diet and must be broken down into monosaccharides by small intestinal enzymes before they can be absorbed into the bloodstream for use by the body. Without this breakdown, none of these disaccharides can be used for energy because they are too big to be absorbed by the intestine.

The small intestine is lined with finger-like projections called microvilli. The microvilli are known collectively as the brush border. The microvilli absorb nutrients from food as it passes through the small intestine.

The Digestive Tract

Enzymatic Reaction

Starch

Individuals with CSID have varying amounts of the enzymes required for starch digestion (for example, isomaltase [palatinase] and maltase), so they may also experience gastrointestinal symptoms after eating foods containing starch.

Carbohydrates

Carbohydrates are classified as either simple or complex. Classification depends on the chemical structure of the food, and how quickly the sugar is digested and absorbed. Simple carbohydrates have one sugar (monosaccharides) or two sugars (disaccharides). Complex carbohydrates have three or more sugars linked together (polysaccharides).

Many complex carbohydrates are starchy carbohydrates, which require ample time and adequate enzymatic activity in the digestive tract to be digested properly. Starch digestion depends on the combination of enzyme activities that occur at several sites in the gastrointestinal tract, from the salivary gland in the mouth, to the pancreas, to the brush border in the small intestine.

Monosaccharides

Simple sugars like glucose and fructose which are found in fruits and honey

Disaccharides

Two molecules of simple sugars such as sucrose, lactose, and maltose

Polysaccharides

Made up of a number of molecules of simple sugars, including starch, glycogen, and cellulose

Digestion of Starches

The digestion of starches begins in the mouth with an enzyme in saliva called salivary amylase, sometimes called ptyalin. Chewing grinds the food and breaks it apart, allowing salivary amylase to work more effectively. After swallowing, the starchy carbohydrates reach the stomach where gastric enzymes begin to break down food.

The stomach plays a major role in digestion by mechanically mixing and crushing the food and enzymatically by further breaking down food. The stomach also acts as a reservoir to facilitate the movement of smaller amounts of food into the small intestine at any given time. The stomach secretes a form of amylase called gastric amylase that further digests starches.

In the small intestine, starch is processed by an enzyme called pancreatic amylase and converted into maltose and sucrose. Maltose and sucrose must be broken down into simple sugars for the body to use as fuel. Individuals with CSID may have difficulty breaking down maltose, since they lack some of the digestive enzymes of the brush border. Throughout the lining of the small intestine, there are normally numerous brush border enzymes (for example, sucrase, lactase, maltase) whose function is to further break down digested food into small, more absorbable particles.

Maltase-glucoamylase is a brush border enzyme that plays a role in the final steps of small intestinal digestion of starch to glucose. Isomaltase is an enzyme that breaks the bonds linking sugars that cannot be broken by amylase or maltase. Glucose is the end product of all starch digestion. After starch is broken down into glucose molecules, the small intestine transports the glucose molecules into the bloodstream, where they are distributed throughout the body to provide energy to virtually all cells, including the brain. If glucose is not immediately used, it may be stored in the liver or skeletal muscle for later use.

Many individuals with CSID have some of the necessary components needed for starch digestion, which includes functional salivary amylase and pancreatic amylase. Problems digesting starch arise with the decreased activity of sucrase-isomaltase and maltase-glucoamylase (brush border enzymes) in the final digestive stages. Approximately 60% to 80% of starch digestion in the small intestine is accounted for by sucrase-isomaltase and 20% to 40% is accounted for by maltase-glucoamylase.4

Due to the presence of maltase-glucoamylase activity, which adds to the digestion of starches, combined with the fact that as one grows, the size of the area that produces digestive enzymes in the small intestine also grows, those with CSID may be able to gradually better tolerate starches as they get older. They should consult their healthcare provider to help determine how much dietary starch they can tolerate.

References
  1. Danialifar TF, Chumpitazi BP, Mehta DI, Di Lorenzo C. Genetic and acquired sucrase-isomaltase deficiency: A clinical review. J Pediatr Gastroenterol Nutr. 2024;78(4):774-82. doi:10.1002/jpn3.12151
  2. National Organization for Rare Disorders. Congenital sucrase-isomaltase deficiency. Last updated February 7, 2018. https://rarediseases.org/rare-diseases/disaccharide-intolerance-i/
  3. Naim HY, Heine M, Zimmer KP. Congenital sucrase-isomaltase deficiency: heterogeneity of inheritance, trafficking, and function of an intestinal enzyme complex. J Pediatr Gastroenterol Nutr. 2012;55(suppl 2):S13-20. doi:10.1097/01.mpg.0000421402.57633.4b
  4. Hamaker BR, Lee BH, Quezada-Calvillo R. Starch digestion and patients with congenital sucrase-isomaltase deficiency. J Pediatr Gastroenterol Nutr. 2012;55(suppl 2):S24-8. doi:10.1097/01.mpg.0000421404.42386.2d

Take Back Control of Your Life

©2025, All Rights Reserved. Presented by QOL Medical, LLC. Do Not Sell/Share My Personal Information
SucraidASSIST.com
View Important Safety Information

IMPORTANT SAFETY INFORMATION:

Collapse Important Safety Information
Expand Important Safety Information

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Tell your doctor if you are allergic to, have ever had a reaction to, or have ever had difficulty taking yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. If you notice any swelling or have difficulty breathing, get emergency help right away.
  • Sucraid® does not break down some sugars that come from the digestion of starch. You may need to restrict the amount of starch in your diet. Your doctor will tell you if you should restrict starch in your diet.
  • Tell your doctor if you have diabetes, as your blood glucose levels may change if you begin taking Sucraid®. Your doctor will tell you if your diet or diabetes medicines need to be changed.
  • Some patients treated with Sucraid® may have worse abdominal pain, vomiting, nausea, or diarrhea. Constipation, difficulty sleeping, headache, nervousness, and dehydration have also occurred in patients treated with Sucraid®. Check with your doctor if you notice these or other side effects.
  • Sucraid® has not been tested to see if it works in patients with secondary (acquired) sucrase deficiency.
  • NEVER HEAT SUCRAID® OR PUT IT IN WARM OR HOT BEVERAGES OR INFANT FORMULA. Do not mix Sucraid® with fruit juice or take it with fruit juice. Take Sucraid® as prescribed by your doctor. Normally, half of the dose of Sucraid® is taken just before a meal or snack and the other half is taken during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Indication

Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.